BRAINLIFE.ORG
|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
26 Number 19
10 September 2024
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
26, Year 2024 >
Number 19, 10 September
|
|
|
|
|
|
Hutton DL, Burns TC, Hossain-Ibrahim K.
A
review of sonodynamic therapy for brain tumors.
Neurosurg
Focus. 2024 Sep 1;57(3):E7. doi:
10.3171/2024.6.FOCUS24338. PMID:
39217635. Review. ˍ
|
|
|
|
Huo X, Li H, Xing Y, Liu W, Chen P, Du F, Song L, Yu Z, Cao X,
Tian J.
Two decades of progress in
glioma methylation research: the rise of temozolomide resistance
and immunotherapy insights.
Front
Neurosci. 2024 Sep 2;18:1440756. doi:
10.3389/fnins.2024.1440756. PMID:
39286478. Bibliometric analysis. ˍ
.
|
|
|
|
*Lerner A, Palmer K, Campion T, Millner TO, Scott E, Lorimer C,
Paraskevopoulos D, McKenna G, Marino S, Lewis R, Plowman
N.
Gliomas in adults: Guidance on
Investigations, Diagnosis, Treatment & Surveillance.
Clin
Med (Lond). 2024 Sep 2:100240. doi:
10.1016/j.clinme.2024.100240. PMID:
39233205. Review. ˍ
|
|
|
|
Ospina JP, Wen PY.
Medical and
neurologic management of brain tumor patients.
Curr
Opin Neurol. 2024 Sep 2;37(6):657-665. doi:
10.1097/WCO.0000000000001315. PMID:
39221926. Guidelines. ˍ
|
|
|
|
Feng F, Shen J, Qi Q, Zhang Y, Ni S.
Empowering
brain tumor management: chimeric antigen receptor macrophage
therapy.
Theranostics.
2024 Sep 3;14(14):5725-5742. doi:
10.7150/thno.98290. PMID:
39310093. Review. ˍ
|
|
|
|
Ospina JP, Wen PY.
Medical and
neurologic management of brain tumor patients.
Curr
Opin Neurol. 2024 Sep 3;37(6):657-665. doi:
10.1097/WCO.0000000000001315. PMID:
39221926. Recommendations. ˍ
|
|
|
|
Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H, Zhang X, Zhang S,
Chen Q.
Targeting ferroptosis opens new
avenues in gliomas.
Int
J Biol Sci. 2024 Sep 3;20(12):4674-4690. doi:
10.7150/ijbs.96476. PMID:
39309434. Review. ˍ
|
|
|
|
Xu Q, Yang C, Wang L, Zhou J.
Unveiling
the role of RNA methylation in glioma: Mechanisms, prognostic
biomarkers, and therapeutic targets.
Cell
Signal. 2024 Sep 3;124:111380. doi:
10.1016/j.cellsig.2024.111380. PMID:
39236835. Review˰ ˍ
|
|
|
|
Mazzoleni A, Awuah WA, Sanker V, Bharadwaj HR, Aderinto N, Tan JK,
Huang HYR, Poornaselvan J, Shah MH, Atallah O, Tawfik A,
Elmanzalawi MEAE, Ghozlan SH, Abdul-Rahman T, Moyondafoluwa JA,
Alexiou A, Papadakis M.
Chromosomal
instability: a key driver in glioma pathogenesis and progression.
Eur
J Med Res. 2024 Sep 4;29(1):451. doi:
10.1186/s40001-024-02043-8. PMID:
39227895. Review. ˍ
|
|
|
|
Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen
HC, Pacheco-Barrios N, Ferreira MY, Batista S, Andreão FF,
Polverini AD, Montenegro TS, Paiva W, Ferreira C, Bertani R,
D'Amico RS.
Advancements and
challenges: immunotherapy therapy in high-grade glioma - a
meta-analysis of randomized clinical trials.
J
Neurooncol. 2024 Sep 4. doi:
10.1007/s11060-024-04813-0. PMID:
39230804. Review˰ ˍ
|
|
|
|
Tao R, Han K, Wu SC, Friske JD, Roussel MF, Northcott PA.
Arrested development: the
dysfunctional life history of medulloblastoma.
Genes
Dev. 2024 Sep 4. doi:
10.1101/gad.351936.124. PMID:
39231614. Review. ˍ
|
|
|
|
*White AJ, Harary M, Casaos J, Everson RG.
Current
immunotherapy techniques in meningioma.
Expert
Rev Anticancer Ther. 2024 Sep 4:1-11. doi:
10.1080/14737140.2024.2399252. PMID:
39233324. Review˰ ˍ
|
|
|
|
Lotsch C, Warta R, Herold-Mende C.
The
Molecular and Immunological Landscape of Meningiomas.
Int
J Mol Sci. 2024 Sep 5;25(17):9631. doi:
10.3390/ijms25179631. PMID:
39273576. Review. ˍ
|
|
|
|
Tataranu LG, Turliuc S, Kamel A, Rizea RE, Dricu A, Staicu GA,
Baloi SC, Rodriguez SMB, Manole AIM.
Glioblastoma
Tumor Microenvironment: An Important Modulator for Tumoral
Progression and Therapy Resistance.
Curr
Issues Mol Biol. 2024 Sep 5;46(9):9881-9894. doi:
10.3390/cimb46090588. PMID:
39329940. Review. ˍ
|
|
|
|
*Yoel A, Adjumain S, Liang Y, Daniel P, Firestein R, Tsui V.
Emerging and Biological Concepts in
Pediatric High-Grade Gliomas.
Cells.
2024 Sep 5;13(17):1492. doi:
10.3390/cells13171492. PMID:
39273062. Review. ˍ
|
|
|
|
Heming CP, Aran V.
The Potential of
Circulating Cell-Free RNA in CNS Tumor Diagnosis and Monitoring: A
Liquid Biopsy Approach.
Crit
Rev Oncol Hematol. 2024 Sep 7:104504. doi:
10.1016/j.critrevonc.2024.104504. PMID:
39251048. Review˰ ˍ
|
|
|
|
Goliot N, Mohssine S, Stefan D, Leclerc A, Emery E, Riverain J,
Missohou F, Geffrelot J, Kao W, Valable S, Balosso J, Lesueur
P.
Proton therapy for adult-type
diffuse glioma: a systematic review.
Crit
Rev Oncol Hematol. 2024 Sep 7:104501. doi:
10.1016/j.critrevonc.2024.104501. PMID:
39251047. Review˰ ˍ
|
|
|
|
Paltin I, Sy M, Lundy SM, Ayr-Volta LK, Canale R, Fong G, Janke K,
Pfeifle GB, Quinton T, Schofield HL, Warren EAH.
Neuropsychological Late Effects and
Quality-of-Life Outcomes in Pediatric Brain Tumor Survivors: Role
of Pediatric Neurologists in Monitoring and Management.
Pediatr
Neurol. 2024 Sep 7;161:149-157. doi:
10.1016/j.pediatrneurol.2024.08.014. PMID:
39383589. Review˰ ˍ
|
|
|
|
Habibi MA, Mirjani MS, Ahmadvand MH, Delbari P, Arab S, Minaee P,
Eazi S, Ahmadpour S.
The clinical
utility of autologous tumor lysate-loaded dendritic cell
vaccination for patients with glioma: A systematic review and
meta-analysis.
Asia
Pac J Clin Oncol. 2024 Sep 8. doi:
10.1111/ajco.14110. PMID:
39244742. Review. ˍ
|
|
|
|
He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B.
Radiogenomics:
bridging the gap between imaging and genomics for precision
oncology.
MedComm
(2020). 2024 Sep 9;5(9):e722. doi:
10.1002/mco2.722. PMID:
39252824. Review. ˍ
|
|
|
|
Kumar A, Shukla R.
Current strategic
arsenal and advances in nose to brain nanotheranostics for
therapeutic intervention of glioblastoma multiforme.
J
Biomater Sci Polym Ed. 2024 Sep 9:1-35. doi:
10.1080/09205063.2024.2396721. PMID:
39250527. Review˰ ˍ
|
|
|
|
Ronsley R, Bertrand KC, Song EZ, Timpanaro A, Choe M, Tlais D,
Vitanza NA, Park JR.
CAR T cell
therapy for pediatric central nervous system tumors: a review of
the literature and current North American trials.
Cancer
Metastasis Rev. 2024 Sep 9. doi:
10.1007/s10555-024-10208-4. PMID:
39251462. Review. ˍ
|
|
|
|
Xu E, Patterson J, Angione A, Li A, Wu DW, Akca E, Elghawy O,
Barsouk A, Sussman JH.
Low-Grade
Glioma Clinical Trials in the United States: A Systematic Review.
Life
(Basel). 2024 Sep 9;14(9):1133. doi:
10.3390/life14091133. PMID:
39337916. Review. ˍ
|
|
|
|
Giuliani P, De Simone C, Febo G, Bellasame A, Tupone N, Di Virglio
V, di Giuseppe F, Ciccarelli R, Di Iorio P, Angelucci S.
Proteomics Studies on Extracellular
Vesicles Derived from Glioblastoma: Where Do We Stand?
Int
J Mol Sci. 2024 Sep 10;25(18):9778. doi:
10.3390/ijms25189778. PMID:
39337267. Review. ˍ
|
|
|
|
Keane L, Cryan JF, Gleeson JP.
Exploiting
the gut microbiome for brain tumour treatment.
Trends
Mol Med. 2024 Sep 10:S1471-4914(24)00222-3. doi:
10.1016/j.molmed.2024.08.008. PMID:
39256110. Review. ˍ
|
|
|
|
Zuo M, Li T, Wang Z, Xiang Y, Chen S, Liu Y.
Research
progress on platelets in glioma.
Chin
Med J (Engl). 2024 Sep 10. doi:
10.1097/CM9.0000000000003282. PMID:
39252160. Review. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|